Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor

Abstract Few treatments have proven effective for patients with chronic spinal cord injury (SCI). This study aimed to evaluate the efficacy and safety of acidic fibroblast growth factor (aFGF) in human SCI. This was an open-label prospective clinical trial of aFGF with an extended follow-up to 48 mo...

Full description

Bibliographic Details
Main Authors: Chin-Chu Ko, Tsung-Hsi Tu, Jau-Ching Wu, Wen-Cheng Huang, Yun-An Tsai, Shih-Fong Huang, Hsueh-Chen Huang, Henrich Cheng
Format: Article
Language:English
Published: Nature Portfolio 2018-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-31083-4